Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-15

Clinical Trial Update: Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing methotrexate delivery via a pre-filled syringe versus a pre-filled pen in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: medac GmbH | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED